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Background: Little is known about the United States diagnosis and burden of pulmonary embolism (PE) in the
emergency department (ED), and their evolution over the past decade. We examined nationally representative data
to evaluate factors associated with and trends in ED diagnosis of PE.
Methods: We conducted a cross-sectional study using National Hospital Ambulatory Medical Care Survey (NHAMCS)
data from January 1, 2001 to December 31, 2010. We identified all ED patient visits where PE was diagnosed and
corresponding demographic, hemodynamic, testing and disposition data. Analyses were performed using descriptive
statistics and multivariable logistic regression.
Results: During the study period 988,000 weighted patient visits with diagnosis of PE were identified. Among patients
with an ED visit, the likelihood of having a diagnosis of PE per year increased significantly from 2001 to 2010 (odds
ratio [OR] 1.091, 95% confidence interval [CI] 1.034-1.152, P = 0.002 for trend) when adjusted for demographic and
hospital information. In contrast, when further adjusted for the use of computed tomography (CT) among patients in
the ED, the likelihood of having a diagnosis of PE per year did not change (OR 1.041, 95% CI 0.987-1.097, P = 0.14).
Overall, 75.1% of patients seen with a diagnosis of PE were hemodynamically stable; 86% were admitted with an
in-hospital death rate under 3%.
Conclusions: The proportion of ED visits with a diagnosis of PE increased significantly from 2001 to 2010 and this rise
can be attributed in large part to the increased availability and use of CT. Most of these patients were admitted with
low in-hospital mortality.
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Pulmonary embolism (PE) is a major national health
problem representing the third most common cause of
death from cardiovascular disease, following heart attack
and stroke [1,2]. The estimated annual economic burden
of PE in the United States (US) exceeds $8.5 billion [3].
Prompt diagnosis and treatment with anticoagulation
has been shown to significantly improve survival [4].
Over the past decade, multidetector-row computed to-
mography pulmonary angiography (CTPA) has become* Correspondence: andrew.einstein@columbia.edu
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minutes to perform and is readily available in most hos-
pital emergency departments (EDs). It is therefore not
surprising that a significant proportion of PEs are diag-
nosed and treatment initiated while the patient is still in
the ED [6].
Recent studies have demonstrated a rise in PE inci-
dence over the past decade commensurate to the in-
creased availability and use of CTPA [7-9]. There is
growing evidence that we may be diagnosing a different,
less severe spectrum of disease with widespread CTPA
utilization [7-9]. At the same time, despite data demon-
strating that approximately half of PEs are diagnosed in
the emergency setting [6,10], few studies have focused
on the epidemiology of PE in the ED. One 22-centerl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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treatments used for suspected or confirmed PEs, but it
is difficult to extrapolate national estimates from these
data [10]. No prior study, to our knowledge, has assessed
US trends in and factors associated with ED visits with
diagnosis of PE at the national level since the introduc-
tion of CTPA.
This study was designed to assess the burden of PE
diagnosed in US EDs since the widespread availability of
CTPA. The National Hospital Ambulatory Medical Care
Survey (NHAMCS) collects objective and reliable infor-
mation about services provided in EDs in the US. Using
this nationally representative sample from 2001 to 2010,
we reviewed patient demographic data, signs and symp-
toms, diagnostic studies ordered and treatments adminis-
tered in the ED. We further assessed patient disposition
(e.g. admission to the hospital), and when possible out-
come data (e.g. death during hospitalization). We then




The NHAMCS is a sample survey of hospital-based out-
patient and ED settings conducted by the Ambulatory and
Hospital Care Statistics Branch of the National Center for
Health Statistics (NCHS), Centers for Disease Control and
Prevention (CDC). The survey is designed to be nationally
representative of the utilization of hospital ambulatory
medical care services. It uses a 4-stage sampling design
that narrows from geographic sampling units to hospitals
within these areas to emergency service areas within these
hospitals to specific patient visits. Each individual patient
visit is weighted using the product of the corresponding
sampling fractions at each stage in the sample design to
produce national estimates. The NCHS then adjusts sam-
pling weights for survey nonresponse. A detailed descrip-
tion of the survey sample design and data acquisition
methods can be found on the CDC website [11]. The
NHAMCS is approved annually by the Ethics Review
Board of NCHS with a waiver of the requirement to
obtain informed consent.
Study sample
The study period January 1, 2001 to December 31, 2010
was selected to represent the burden of PE after the
introduction of CTPA in 1998 [7]. NHAMCS data from
1998–2000 does not contain hemodynamic data. More-
over, it may represent a period when many EDs did not
yet have CTPA and therefore these data were not in-
cluded. NHAMCS data from after 2010 is not yet pub-
licly available for review.
The NHAMCS records up to three diagnoses for
each visit, which are later converted to InternationalClassification of Disease, Ninth Revision (ICD-9) codes.
The ICD-9 codes used to extract all visits with a
diagnosis of PE were 415.11 and 415.19. These codes
have previously been validated in administrative data
[12]. Sensitivity analysis was performed excluding visits
where PE was listed as the non-first diagnosis. ED visits
were stratified by patient demographics and expected
primary source of payment (private/commercial in-
surance, Medicare/Medicaid, and other). We subcate-
gorized age into those patients under 65 years-old and
those 65 years and older, the age cutoff used in the revised
Geneva score [13]. We examined clinical characteristics
including vital signs at presentation (heart rate [HR] and
systolic blood pressure [SBP]), and use of diagnostic tes-
ting (computed tomography [CT] and/or magnetic re-
sonance imaging [MRI]). We defined hemodynamically
stable patients as those having HR < 110 beats per minute
and SBP > 100 mmHg, based on cutoffs from the pul-
monary embolism severity index for prognostication in
patients with acute symptomatic PE [14,15]. We catego-
rized disposition into admission (NHAMCS value of
admitted to the hospital, admitted to ICU/CCU, admitted
to observation, transferred to other medical facility), death
(NHAMCS value of death on arrival or death in ED), and
all other dispositions (e.g. discharged or left against
medical advice). Finally, we collected limited information
about the hospitals including geographic region (Northeast,
Midwest, South, and West) and whether the hospital was
part of a Metropolitan Statistical Area (MSA). US popula-
tion data were obtained using US Census Bureau intercen-
sal resident population estimates [16]. A small proportion
(<10%) of variables had missing data and these visits were
excluded from the relevant analyses.
NHAMCS collected a combined CT and MRI variable
between 2001 and 2004. We combined MRI and CT vari-
ables from the subsequent years to generate a dichoto-
mous variable throughout the study period that indicates
if a CT and/or MRI were performed during the patient
visit. We then determined the percentage of patients who
underwent MRI alone from 2005–2010 to assess the
impact of combining the MRI and CT variables.
Statistical analysis
Descriptive statistics were determined for patient visit
characteristics and multivariable logistic regression con-
trolling for patient demographics (age, race, sex) and
hospital information (region, Metropolitan Statistical Area
status) was used to assess any trends in PE diagnoses
among patients who had ED visits over time. We per-
formed an additional multivariable logistic regression
controlling for CT and/or MRI use in addition to patient
demographics and hospital information. The NCHS guide-
lines state that estimates based upon fewer than 30 raw
observations or with a relative standard error greater than
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vations, we stratified visits into 2 year blocks for national
estimates and figures. We also combined the first 5 years
of the study period (2001–5) and compared these data
from the subsequent 5 years (2006–10) to assess any for
any changes. This ensured most variables contained
sufficient raw data to generate robust national estimates.
All statistical analyses were performed in Stata/SE 11.0
and 13.0 (StataCorp, College Station, Texas) using the svy
command to account for the NHAMCS sampling metho-
dology [17].
Results
A total of 357,681 patient visits representing 1,182,758,000
weighted ED visits (95% confidence interval [CI]
1,060,000,000-1,300,000,000) within NHAMCS from 2001
to 2010 were reviewed. Of these, 283 ED visits represen-
ting 988,000 weighted visits (95% CI 783,000-1,193,000)
were identified with diagnosis of PE (approximately 0.08%Table 1 Demographic and clinical data
ED visits for PE
Characteristic No. of obs. Weight
Overall 283 0.08%
Sex Male 123 45.2%
Female 160 54.8%
Age category Under 65 years 162 55.8%
65 years and over 121 44.2%
Race/ethnicity White 223 80.1%
Black 55 19.1%
Other 5 0.8%
Payment source Private insurance 104 36.4%
Medicare/Medicaid 148 55.6%
Other 26 8.0%




Hemodynamics Unstable 71 24.9%
Stable 203 75.1%
CT or MRI Yes 154 57.7%
No 129 42.3%
Disposition Admission/Transfer 233 86.3%
Other 43 10.4%
Death on Arrival/in ED 7 3.4%
MSA MSA 243 85.5%
Non-MSA 40 14.5%
**Indicates insufficient observations to generate reliable confidence intervals. ED = e
tomography; MRI = magnetic resonance imaging; MSA =Metropolitan Statistical Are
Summary of demographic, clinical and hospital data for visits with a diagnosis of PEof total weighted ED visits). Among these, 64.0% (95% CI
60.6-67.5%) had PE as the first listed diagnosis. Sensitivity
analysis excluding visits where PE was not listed as the
first diagnosis showed no significant change in our results.
Table 1 includes a summary of demographic, clinical
and hospital information for visits with a diagnosis of PE
and all other ED visits for comparison. The mean age of
patients seen in the ED with a diagnosis of PE was
59 years-old as compared to a mean age of 36 years-old in
patients seen in the ED for all other reasons (p < 0.0001).
A greater proportion of patients with a diagnosis of PE
were white (80.1%) when compared to patients in the ED
for all other diagnoses (73.8%), (P = 0.022). There were
also regional differences, with a greater proportion of
visits for PE in the Midwest and West (P = 0.021). Most
visits to the ED were in Metropolitan Statistical Areas for
both patients with a diagnosis of PE and all other ED visits
(P = 0.57). There was no statistically significant difference
in sex between ED visits with a diagnosis of PE and allAll other ED visits
ed % (±95% CI) Weighted % (±95% CI) P-value
0.01% 99.92% (0.77%)
(3.8%) 45.8% (0.7%) 0.88
(3.8%) 54.2% (0.7%)
(3.4%) 85.2% (0.2%) <0.0001
(3.4%) 14.8% (0.2%)
(3.2%) 73.8% (1.1%) 0.022
(3.2%) 22.7% (1.1%)
** 3.5% (0.3%)
(3.3%) 37.0% (0.5%) <0.0001
(3.1%) 41.6% (0.5%)
** 21.5% (0.4%)




(3.5%) 24.7% (0.3%) 0.96
(3.5%) 75.3% (0.3%)
(4.0%) 11.6% (0.3%) <0.0001
(4.0%) 88.4% (0.3%)
(2.7%) 14.7% (0.3%) <0.0001
(2.0%) 85.1% (0.3%)
** 0.2% (0.01%)
(4.5%) 83.4% (3.3%) 0.57
(4.5%) 16.6% (3.3%)
mergency department; No. = number; Obs. = observations; CT = computed
a.
and all other ED visits for comparison.
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portion (approximately 54%) in both groups (P = 0.88).
Approximately 75.1% of patient visits with a diagnosis of
PE were hemodynamically stable with no significant dif-
ference when compared to all other ED visits (P = 0.96).
About 57.7% of weighted visits with a diagnosis of PE
involved CT or MRI, compared to 11.6% in all other ED
visits (P < 0.0001). During 2005–10, the period where MRI
and CT were separate variables, there were no visits with
a diagnosis of PE involving MRI alone. MRI was per-
formed in 3 unweighted patient visits for PE. CT was also
performed during all these visits.
About 86.3% of patients with a diagnosis of PE were
admitted or transferred to another medical facility from
the ED, compared to 14.7% of patients seen with all
other diagnoses (P < 0.0001). There were 7 unweighted
patient visits where the patient was dead on arrival or
died in the ED during the study period, which would
translate roughly to 3.4% of weighted visits, but the sam-
ple is too small to generate robust CIs. From 2005–10,
when hospital discharge data were available, 3 un-
weighted patient visits were admitted and died prior to
discharge, representing approximately 2.8% of all ED
visits for PE admitted during this period, though the
number of observations does not permit generation of
robust CIs.
Over the study period there was a gradual increase in
the total US population and number of ED visits. This
same period experienced a significant rise in the number
of ED visits for PE (see Figure 1). In 2009 and 2010Figure 1 Trends in ED visits with a diagnosis of PE over time. Shows t
ED visits over time in two-year intervals.combined there were 267,000 (95% CI 184,000-351,000)
ED visits with a diagnosis of PE compared with 105,000
(95% CI 67,000-143,000) in 2001 and 2002. Among pa-
tients seen in the ED, the likelihood of having a diagno-
sis of PE per year increased significantly over the period
2001 to 2010 (OR 1.091, 95% CI 1.034-1.152, P = 0.002
for trend) when adjusted for demographic (age, race,
sex) and hospital information (region, Metropolitan
Statistical Area status). In contrast, when further adjusted
for the use of CT and/or MRI, the likelihood of having a
diagnosis of PE per year did not change over the study
period (OR 1.041, 95% CI 0.987-1.097, P = 0.14). Table 2
summarizes the association of demographic variables and
hospital information with the likelihood of a visit for PE.
Table 3 compares the first five years of the study
period (2001–5) with the later five years (2006–10). A
significantly greater proportion of patients underwent
CT or MRI imaging in the later period (69.2% compared
to 37.9%, P < 0.0001). There was no difference in sex or
race between the two time periods. Although a greater
proportion of patients during the later years were
65 years and over (48.0% compared with 37.7%), this
difference did not reach statistical significance (P = 0.17).
There was no change in the proportion of patients who
were hemodynamically unstable or rate of admission/
transfer. While not shown in the table, there was also no
difference between 5 year periods in geographic locations
(geographic region or proportion in a Metropolitan Statis-
tical Area) where PEs occurred (P = 0.65 and P = 0.32,
respectively).rends in US population, ED visits with a diagnosis of PE and all other
Table 2 Results of logistic regression model assessing relationship between demographic data and likelihood of
PE diagnosis
Excluding CT and/or MRI data Including CT and/or MRI data
OR 95% CI P-value OR 95% CI P-value
Time (in 1 year intervals) 1.091 (1.034 1.152) 0.002 1.041 (0.987 1.097) 0.14
Age 1.038 (1.033 1.042) <0.001 1.031 (1.026 1.036) <0.001
Male 1.094 (0.805 1.487) 0.560 1.098 (0.807 1.492) 0.55
Race White 1 - - - - - - 1 - - - - - -
Black 1.050 (0.728 1.515) 0.790 1.162 (0.803 1.682) 0.43
Other 0.200 (0.074 0.542) 0.002 0.197 (0.074 0.528) 0.001
Region Northeast 1 - - - - - - 1 - - - - - -
Midwest 1.518 (0.978 2.348) 0.061 1.463 (0.957 2.237) 0.079
South 0.913 (0.547 1.523) 0.730 0.924 (0.562 1.521) 0.76
West 1.511 (0 .967 2.364) 0.070 1.589 (1.019 2.478) 0.041
Within MSA 0.803 (0.466 1.386) 0.430 1.012 (0.591 1.731) 0.97
Use of CT and/or MRI Not included 7.003 (5.100 9.616) <0.001
Demographic variables and hospital information associated with the likelihood of a PE diagnoses among patients seen in the ED. Table includes data both
adjusted and not adjusted for the use of CT and/or MRI.
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Over the past decade, the diagnosis of PE has remained
an important public health issue. Our findings here
demonstrate that the number of patients seen in the ED
who were given a diagnosis of PE more than doubled
from 2001 to 2010. However, when adjusted for CT
utilization, there was no significant rise over this time
period in the likelihood of a diagnosis of PE among
patients seen in the ED. Thus, the apparent rise in ED
visits with a diagnosis of PE may be attributed in largeTable 3 Comparison of PE ED visits during first and second h
ED visits for PE
2001-2005
Characteristic No. of obs. Weighted %
Age Under 65 years 75 62.3%
65 years and over 48 37.7%
Sex Male 53 43.9%
Female 70 56.1%
Race White 100 80.1%
Black 21 18.8%
Other 2 1.1%
Hemodynamics Stable 84 75.2%
Unstable 30 24.8%
CT or MRI Yes 46 37.9%
No 77 62.1%
Disposition Admission/Transfer 96 88.8%
Discharge from ED 23 11.8%
Death on Arrival/in ED 4 1.9%
**Indicates insufficient observations to generate reliable confidence intervals.
Comparison of demographic, clinical and hospital data between the first (2001–5) apart to the increased availability and use of CTPA, rather
than reflecting a true rise in the incidence of PEs in the
US. An aging population may have contributed to a true
increase in PE diagnosis [18,19], but our data do not
show a significant change in the proportion of patients
with a diagnosis of PE 65 years and over during the
study period. None of the other variables assessed
changed significantly during the study period, including
sex, race, geographic region, Metropolitan Statistical
Area status, hemodynamic status, and admission to thealf of study period
2006-2010
(95% CI) No. of obs. Weighted % (95% CI) P-value
(5.6%) 87 52.1% (4.5%) 0.17
(5.6%) 73 48.0% (4.5%)
(5.6%) 70 46.0% (5.1%) 0.78
(5.6%) 90 54.0% (5.1%)
(5.8%) 123 80.1% (4.0%) 0.87
** 34 19.3% (4.0%)
** 3 0.6% **
(4.7%) 119 75.1% (4.6%) 0.99
(4.7%) 41 24.9% (4.6%)
(5.7%) 108 69.2% (4.7%) <0.0001
(5.7%) 52 30.8% (4.7%)
(3.0%) 137 90.5% (2.8%) 0.59
** 20 9.5% **
** 3 4.2% **
nd second (2006–10) half of the study period associated with ED visits for PE.
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CTPA has contributed to the substantial increase in PE
diagnosis.
Our data further suggest that many patients given a
diagnosis of PE in the ED may have been unnecessarily
hospitalized. Most patients in EDs with a diagnosis of PE
were hemodynamically stable at presentation, with sta-
bility defined using cutoff values from the pulmonary
embolism severity index for prognostication in patients
with acute symptomatic PE [14,15]. Subsequent in-
hospital mortality was under 3%, which agrees with the
low mortality rates recently reported in in 22 community
and academic EDs in the US [10]. The vast majority of
patients with a diagnosis of PE were nonetheless admit-
ted to the hospital. Rates of admission for patients with
a diagnosis of PE in the ED remained stable throughout
the study period at approximately 86%, compared to
approximately 15% for all other ED visits.
There is now good evidence that hemodynamically
stable patients should be considered candidates for out-
patient management. We observed, however, than only
about 10% of ED PE patients were discharged from the
ED for outpatient management. Recommended prereq-
uisites for outpatient management include the absence
of serious co-morbid conditions (e.g. significant heart
disease, renal or liver failure) or recent bleeding, as well
as adequate social support [20-24]. Recently published
data suggest that approximately 50% of patients with
acute PE can be treated safely as outpatients [20-22].
There is great potential for healthcare cost savings; the
average cost of admission for PE in a recent analysis was
over $8,000 [25].
Over the study period, ED visits that included a diag-
nosis of PE comprised approximately 0.08% of all ED
visits. Those diagnosed with PE in the ED were older
than the population seen in the ED with diagnoses ex-
clusive of PE, not surprising since older age is a known
risk factor for PE [26]. Nonetheless, most visits with a
diagnosis of PE in the ED (approximately 56%) were
under 65 years old, which agrees with data recently
reported in a multicenter study assessing clinical charac-
teristics of suspected or confirmed PEs in the ED [10].
Our data further reinforces the need to consider PE
among younger patients.
There were a number of limitations to our study. The
retrospective design limits the data available for analysis.
For example, the use of ICD-9 codes to identify visits for
PE does not differentiate between suspected and con-
firmed PEs. Furthermore, we cannot assess how the PE
was diagnosed and whether or not the PE was acute,
chronic, or recurrent. While the use of ICD-9 codes has
been validated in hospitalized patients [12], there is data
to suggest that PE diagnostic codes reported in EDs
should be used with caution [27]. It is therefore possiblethat the true incidence of PE has not changed and that
our observed increase is largely related providers more
often including PE as a provisional diagnosis in the ED.
We nonetheless feel this is an important finding – ED
doctors may be more often considering the diagnosis of
PE in the era of more readily available CTPA. It is also
possible that patients with chronic or recurrent PEs are
presenting to the ED with increased frequency. While it
is likely that some PEs were not diagnosed in the ED, we
do not believe this underestimation would have changed
over time and therefore trend analysis should not have
been significantly impacted. Since NHAMCS had a com-
bined CT and MRI variable between 2001 and 2004, we
cannot distinguish which of the two technologies were
utilized. However, this is unlikely to pose a significant
problem—there were no patient visits with a diagnosis
of PE in the ED that underwent MRI alone between
2005 and 2010, and therefore it can be assumed that no
or very few patients underwent MRI alone when the
combined CT/MRI variable was reported positive be-
tween 2001 and 2004. NHAMCS does not include data
on the utilization of ventilation/perfusion lung scans.
Since mortality in patients diagnosed with PE was infre-
quent, we were unable to generate robust confidence in-
tervals for these characteristics or assess for trends. We
can, however, confidently conclude that in-hospital mor-
tality in patients diagnosed with PE in the ED was very
low and this agrees with recently reported data [10].
Finally, it is possible that the changing demographics of
the US population could account for the increase in
proportion of ED visits with a diagnosis of PE.
Conclusions
Our data demonstrate that the burden of PE diagnosis in
US EDs has risen substantially over the past decade.
This increase is at least in part attributable to greater
CT utilization. The majority of patients with an ED diag-
nosis of PE were hemodynamically stable and therefore
likely candidates for outpatient management, yet over
eighty percent were admitted for in hospital treatment.
There may be substantial opportunity for cost savings by
developing protocols to better define those patients that
are appropriate for outpatient management.
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